BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 21537704)

  • 1. Breast histomorphometry of rats treated with estrogen and/or progestogen.
    Torres SM; Simões RS; Baracat MC; Gomes RC; Soares Júnior JM; Carbonel AA; Baracat EC
    Rev Assoc Med Bras (1992); 2011; 57(2):177-81. PubMed ID: 21537704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sustained effects on synthetic ovarian steroids of rat myometrial contractility.
    Parkington HC; Lipton A
    J Endocrinol; 1976 Aug; 70(2):223-7. PubMed ID: 965882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of early and late treatment with soy isoflavones in the mammary gland of ovariectomized rats.
    Santos MA; Florencio-Silva R; Teixeira CP; Sasso GR; Marinho DS; Simões RS; Simões MJ; Carbonel AF
    Climacteric; 2016; 19(1):77-84. PubMed ID: 26606166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is expression of rat breast matrix components influenced by estrogen, progestins and tibolone?
    Cunha EP; Pompei LM; Theodoro TR; Steiner ML; Silva VF; Silveira ER; Mader AM; Pinhal MA; Fernandes CE
    Climacteric; 2015; 18(4):523-7. PubMed ID: 25603456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional profiles of progestogen effects in the postmenopausal breast.
    Wood CE; Register TC; Cline JM
    Breast Cancer Res Treat; 2009 Mar; 114(2):233-42. PubMed ID: 18404370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Breast histologic changes in female rats treated with sex steroids].
    Vicelli JT; Gurgel MS; Alvarenga M
    Rev Assoc Med Bras (1992); 2006; 52(5):369-74. PubMed ID: 17160316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative analysis of the uterine and mammary gland effects of progesterone and medroxyprogesterone acetate.
    Otto C; Fuchs I; Vonk R; Fritzemeier KH
    Maturitas; 2010 Apr; 65(4):386-91. PubMed ID: 20036471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphometric evaluation of effects of two sex steroids on mammary gland of female rats.
    Pompei LM; Carvalho FM; Ortiz SC; Motta MC; Cruz RJ; Melo NR
    Maturitas; 2005 Aug; 51(4):370-9. PubMed ID: 16039410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of estradiol, progestogens, and of tibolone on breast proliferation and apoptosis.
    Pompei LM; Cunha EP; Steiner ML; Theodoro TR; Mader AM; Petri G; Pinhal MA; Fernandes CE
    Climacteric; 2015; 18(4):518-22. PubMed ID: 25830529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacodynamic effects of once-a-month combined injectable contraceptives.
    Sang GW
    Contraception; 1994 Apr; 49(4):361-85. PubMed ID: 8013220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of progestogen on lipids, lipoproteins and apolipoproteins during transdermal estrogen replacement therapy with and without medroxyprogesterone acetate.
    Castelo-Branco C; Casals E; Sanllehy C; Duran M; Fortuny A; Vanrell JA
    J Reprod Med; 1996 Nov; 41(11):833-8. PubMed ID: 8951134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Additional effects of medroxyprogesterone acetate on mammary tumors in oophorectomized, estrogenized, DMBA-treated rats.
    Sakamoto S; Kudo H; Suzuki S; Mitamura T; Sassa S; Kuwa K; Chun Z; Yoshimura S; Maemura M; Nakayama T; Shinoda H
    Anticancer Res; 1997; 17(6D):4583-7. PubMed ID: 9494572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How to use progestin in hormone replacement therapy: an animal experiment.
    Sun A; Wang J; Zhu P
    Chin Med J (Engl); 2001 Feb; 114(2):173-7. PubMed ID: 11780201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the proliferative effects of estradiol and conjugated equine estrogens on human breast cancer cells and impact of continuous combined progestogen addition.
    Mueck AO; Seeger H; Wallwiener D
    Climacteric; 2003 Sep; 6(3):221-7. PubMed ID: 14567770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contrasting effects of two hormone replacement therapies on the cardiovascular and mammary gland outcomes in surgically postmenopausal monkeys.
    Suparto IH; Williams JK; Cline JM; Anthony MS; Fox JL
    Am J Obstet Gynecol; 2003 May; 188(5):1132-40. PubMed ID: 12748457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of long-term treatment with 17 beta-estradiol and medroxyprogesterone acetate on water maze performance in middle aged female rats.
    Lowry NC; Pardon LP; Yates MA; Juraska JM
    Horm Behav; 2010 Jul; 58(2):200-7. PubMed ID: 20362580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive effects of long-term dydrogesterone treatment used alone or with estrogen on rat menopausal models of different ages.
    Liu J; Lin H; Huang Y; Liu Y; Wang B; Su F
    Neuroscience; 2015 Apr; 290():103-14. PubMed ID: 25637796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of high doses of genistein on mammary gland of female rat].
    Carbonel AA; Santos RH; Simões RS; Silva RF; Soares JM; Baracat EC; Haidar MA
    Rev Bras Ginecol Obstet; 2011 Sep; 33(9):264-9. PubMed ID: 22189855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Individual and combined effects of relaxin, estrogen, and progesterone in ovariectomized gilts. II. Effects on mammary development.
    Winn RJ; Baker MD; Merle CA; Sherwood OD
    Endocrinology; 1994 Sep; 135(3):1250-5. PubMed ID: 8070370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progesterone receptor antagonism inhibits progestogen-related carcinogenesis and suppresses tumor cell proliferation.
    Lee O; Choi MR; Christov K; Ivancic D; Khan SA
    Cancer Lett; 2016 Jul; 376(2):310-7. PubMed ID: 27080304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.